Renal Insufficiency, Chronic: Clinical Trials

4,744 trials for Renal Insufficiency, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2649 completed, 703 unknown, 469 recruiting, 289 terminated. 1665 Not applicable, 590 Phase 2, 519 Phase 4, 502 Phase 3, 360 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1665Completed 913, Unknown 256, Recruiting 165, Not yet recruiting 112, Terminated 98, Active not recruiting 68, Withdrawn 35, Enrolling by invitation 17, Suspended 1
Phase 2590Completed 359, Terminated 59, Unknown 58, Recruiting 48, Withdrawn 23, Not yet recruiting 18, Active not recruiting 15, Enrolling by invitation 6, Suspended 4
Phase 4519Completed 286, Unknown 99, Terminated 36, Recruiting 35, Withdrawn 28, Active not recruiting 15, Not yet recruiting 14, Enrolling by invitation 4, Suspended 2
Phase 3502Completed 318, Terminated 54, Unknown 46, Recruiting 35, Active not recruiting 19, Withdrawn 16, Not yet recruiting 10, Enrolling by invitation 2, Suspended 2
Phase 1360Completed 240, Recruiting 36, Unknown 26, Terminated 24, Not yet recruiting 14, Active not recruiting 12, Withdrawn 6, Enrolling by invitation 1, Suspended 1
Early Phase 132Completed 17, Recruiting 6, Not yet recruiting 3, Enrolling by invitation 2, Withdrawn 2, Active not recruiting 1, Terminated 1

Follow Renal Insufficiency, Chronic: new trials by email Literature Review of Renal Insufficiency, Chronic trials Research Report on Renal Insufficiency, Chronic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MRI Technical Development and Applications in Kidney Disease
Chronic Kidney Diseases, Kidney Transplantation
Not yet recruitingUniversity of Minnesota1802028-06-302026-04-13
Veteran Centered Meal Intervention in Chronic Kidney Disease
Medically tailored meals (MTMs) - Chronic Kidney Disease
Not applicableNot yet recruitingVA Office of Research and Development1002027-10-012026-09-03
Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases
Not applicableNot yet recruitingState University of New York at Buffalo5502027-10-012026-10-20
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
Kidney RISE: Randomized Integrated Supportive CarE Trial
Kidney RISE - Chronic Kidney Disease (Stages 4 and 5)
Not applicableNot yet recruitingNYU Langone Health2802027-05-012026-08-03
Breakthrough - T1DM and Chronic Kidney Disease
Tegoprubart, Islet Cell Transplant - Diabete Type 1, Chronic Kidney Disease
Phase 1 / Phase 2RecruitingUniversity of Chicago102027-04-292026-08-20
PATH-03 Paraguay Feasibility Study
ePATH System will be used to create an endoAVF - Kidney Disease, End-Stage
Not applicableNot yet recruitingPathfinder Medical202027-03-012026-09-17
Drone Transport of Deceased-Donor Kidney Grafts Between Two French Hospitals Before Transplantation: a Pilot Safety Study
Kidney graft transport by autonomous unmanned aircraft (drone) between the procurement and transplantation centres - Kidney Failure, Chronic, Kidney Transplantation
Not applicableNot yet recruitingNantes University Hospital52027-01-152026-10-01
Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease
Standard Table Salt, Salt Substitute - End Stage Kidney Disease
Not applicableNot yet recruitingNYU Langone Health202027-01-152026-03-12
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Semaglutide, Virtual Weight Management Coaching - Obesity, Chronic Kidney Disease
Phase 4Not yet recruitingKristin Clemens8802027-01-012026-10-05
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Finerenone (BAY94-8862 ) 10 mg, Placebo - Acute Kidney Injury, Renal Insufficiency,Chronic
Not applicableNot yet recruitingJean-Maxime Côté722027-01-012026-08-20
Virtual Reality-Guided Imagery in Hemodialysis Patients ( VRGI-HD )
virtual reality-guided imagery (VRGI) - End-Stage Kidney Disease (ESKD)
Not applicableNot yet recruitingIslamic University of Najaf802027-01-012026-10-09
Impact of Reducing the Dialysate Flow Rate in Chronic Hemodialysis on Dialysis Quality and Environmental Impact on Water Consumption
Dialysate flow at 400mL/min, Dialysate flow at 500mL/min - Kidney Disease, Chronic
Not applicableNot yet recruitingAssistance Publique Hopitaux De Marseille2502027-01-012026-07-22
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study
Dialysis, Chronic Kidney Disease (Stages 3b-5)
Not yet recruitingPrince of Wales Hospital, Shatin, Hong Kong402026-12-052026-09-16
Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency
Dorzagliatin, Linagliptin - Type 2 Diabetes Mellitus (T2DM), Chronic Renal Insufficiency
Not applicableWithdrawnSun Yat-sen University2026-12-012026-10-16
Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.
Spironolactone (drug), Iron Supplement, Erythropoietin stimulating agent - Anemia
Phase 2Not yet recruitingAin Shams University402026-12-012026-07-20
Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony
PD cycler - Renal Failure, Chronic Kidney Disease
Not applicableNot yet recruitingFresenius Medical Care Deutschland GmbH242026-12-012026-09-03
Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A PragmaTIC Cluster Randomized Controlled Trial (HOLISTIC)
The intervention with the MCM is Kidney-Heart GDMT initiation and titration for dose optimization (as clinically tolerated), within 4 months of enrollment in the study. - Chronic Kidney Disease, Type II Diabetes
Phase 4Not yet recruitingBaim Institute for Clinical Research5702026-12-012026-09-10
Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring
Continuous Glucose Monitoring (CGM) - End Stage Kidney Disease (ESKD), Hyperglycaemia
Not yet recruitingEmory University1802026-12-012026-10-19

Showing 20 of 4744. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (1997)  ·  Renal Insufficiency (282)  ·  Kidney Diseases (262)  ·  Hypertension (231)  ·  Anemia (228)  ·  Diabetes Mellitus (224)  ·  Diabetes Mellitus, Type 2 (204)  ·  Cardiovascular Diseases (180)  ·  Heart Failure (131)  ·  Acute Kidney Injury (124)  ·  Inflammation (105)  ·  Hyperparathyroidism, Secondary (95)  ·  Motor Activity (94)  ·  Diabetic Nephropathies (93)

Broader conditions

Pathological Conditions, Signs and Symptoms (4744)  ·  Disease Attributes (4743)  ·  Female Urogenital Diseases (4743)  ·  Female Urogenital Diseases and Pregnancy Complications (4743)  ·  Male Urogenital Diseases (4743)  ·  Pathologic Processes (4743)  ·  Urogenital Diseases (4739)  ·  Urologic Diseases (4726)  ·  Chronic Disease (4715)  ·  Kidney Diseases (4482)  ·  Renal Insufficiency (4462)  ·  Nutritional and Metabolic Diseases (888)  ·  Metabolic Diseases (786)  ·  Endocrine System Diseases (619)

Interventions

Exercise (67)  ·  Darbepoetin alfa (54)  ·  dapagliflozin (49)  ·  paricalcitol (47)  ·  Epoetin Alfa (46)  ·  Sevelamer (46)  ·  Blood Specimen Collection (45)  ·  finerenone (39)  ·  Tacrolimus (35)  ·  Cholecalciferol (34)  ·  Cinacalcet (34)  ·  Mycophenolic Acid (33)  ·  Standard of Care (32)  ·  empagliflozin (32)  ·  Spironolactone (29)

Sponsors

Amgen (68)  ·  Bayer (54)  ·  AstraZeneca (53)  ·  Assiut University (45)  ·  National Taiwan University Hospital (37)  ·  Vantive Health LLC (34)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (33)  ·  University of Pennsylvania (29)  ·  VA Office of Research and Development (28)  ·  Duke University (27)  ·  University of Washington (27)  ·  Novo Nordisk A/S (26)  ·  Brigham and Women's Hospital (24)  ·  Hospices Civils de Lyon (24)  ·  Massachusetts General Hospital (24)

Countries

United States (1590)  ·  France (346)  ·  China (326)  ·  Canada (312)  ·  Germany (306)  ·  United Kingdom (299)  ·  Spain (234)  ·  Italy (226)  ·  Taiwan (184)  ·  South Korea (171)  ·  Brazil (167)  ·  Poland (163)  ·  Belgium (150)  ·  Denmark (149)  ·  Turkey (Türkiye) (141)

Top investigators

Alp Ikizler, MD (17)  ·  Jonathan Himmelfarb, MD (10)

Results publications

PMID 36005278, PMID 40576086, PMID 35018639, PMID 36791280, PMID 35224730, PMID 37916745, PMID 33586138, PMID 37870148, PMID 32390133, PMID 38189593, PMID 33283264, PMID 34164803, PMID 36472416, PMID 37651553, PMID 32588430, PMID 33782940, PMID 38018702, PMID 38770818, PMID 33107592, PMID 39963952, PMID 23797006, PMID 41196655, PMID 19558344, PMID 23343061, PMID 23343062, PMID 32446407, PMID 32734207, PMID 36039153, PMID 38899545, PMID 39356039, PMID 39498822, PMID 40333016, PMID 40359056, PMID 41198855, PMID 41805697, PMID 18328118, PMID 20721651, PMID 23732715, PMID 27587605, PMID 28506446, PMID 28756065, PMID 28767349, PMID 30677788, PMID 31203241, PMID 33118160, PMID 34231877, PMID 36472884, PMID 36749544, PMID 37872654, PMID 37968132

NIH funding

2023 (32), 2016 (16), 2015 (14), 2025 (13), 2009 (12), 2014 (11), 2008 (10), 2017 (10), 2018 (10), 2019 (9), 2004 (5), 2005 (5), R01DK045604 (3), R01DK071696 (3), K01DK139400 (2)